MUC1 and breast carcinoma: On the other hand, this strategy of polyvalent vaccines has been evaluated in other tumors such as breast cancer with Globo-H-GM2-Lewis-Y-MUC1-32(aa)-STn(c)-TF(c)-Tn(c)-KLH conjugate + QS21 (NCT00030823); and SCLC with GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid -KLH conjugate + OPT-821 (NCT01349647).